Repositorio Dspace

Listar por tema "Natriuretic Peptide, Brain/blood"

Listar por tema "Natriuretic Peptide, Brain/blood"

Ordenar por:Orden:Resultados:

  • Colchicine in acute heart failure: Rationale and design of a randomized double-blind placebo-controlled trial (COLICA) 
    Pascual-Figal, Domingo-A; Villota, Julio-Nunez; Pérez-Martínez, María-Teresa; González-Juanatey, José-Ramón; Taibo-Urquia, Mikel; Llacer-Iborra, Pau; González-Martín, Javier; Villar, Sandra; Soler, Meritxel; Mirabet, Sonia; Aimo, Alberto; Riquelme-Pérez, Alejandro; Anguita-Sánchez, Manuel; Martínez-Sellés, Manuel; Sánchez, Pedro-Luis; Ibáñez, Borja; Bayés-Genís, Antoni (Wiley, 2024-09)
    AIMS: Heart failure (HF) elicits a pro-inflammatory state, which is associated with impaired clinical outcomes, but no anti-inflammatory therapies have demonstrated a clinical benefit yet. Inflammatory pathways related ...
  • Galectin-3 and ß-trace protein concentrations are higher in clinically unaffected patients with Fabry disease 
    Hernández-Romero, Diana; Sánchez-Quinones, Jessica; Vílchez, Juan-Antonio; Rivera-Caravaca, José-Miguel; de-la-Morena-Valenzuela, Gonzalo; Lip, Gregory-Y-H; Climent, Vicente; Marín, Francisco (NATURE PORTFOLIO, 2019-04-17)
    Current therapies have not shown benefit in organ damage reversal in Fabry disease (FD), but biomarkers could help risk stratification and prognosis. We investigated if several biomarkers of cardiac fibrosis, cardiac wall ...
  • Increased plasma levels of N-terminal pro-B-type natriuretic peptide as biomarker for the diagnosis of cardioembolic ischaemic stroke 
    García-Carmona, JA; Conesa-García, E; Vidal-Mena, D; González-Morales, M; Ramos-Arenas, V; Sánchez-Vizcaino-Buendia, C; Soria-Torrecillas, JJ; Pérez-Vicente, JA; García-de-Guadiana-Romualdo, L (ELSEVIER ESPANA SLU, 2024-07)
    BACKGROUND: Despite comprehensive study, the aetiology of stroke is not identified in 35% of cases. AIMS: We conducted a study to assess the diagnostic capacity of N-terminal pro-B-type natriuretic peptide (NT-proBNP) in ...
  • Long-Term Stroke Risk Prediction in Patients With Atrial Fibrillation: Comparison of the ABC-Stroke and CHA2DS2-VASc Scores 
    Rivera-Caravaca, José-Miguel; Roldán-Schilling, Vanessa; Esteve-Pastor, María-Asunción; Valdés-Chavarri, Mariano; Vicente, Vicente; Lip, Gregory-Y-H; Marín, Francisco (WILEY, 2017-07)
    BACKGROUND: The ABC-stroke score (age, biomarkers [N-terminal fragment B-type natriuretic peptide, high-sensitivity troponin], and clinical history [prior stroke/transient ischemic attack]) was proposed to predict stroke ...
  • N-terminal pro-B-type natriuretic peptide post-discharge monitoring in the management of patients with heart failure and preserved ejection fraction - a randomized trial: The NICE study 
    Pascual-Figal, Domingo-A; Hernández-Vicente, Álvaro; Pastor-Pérez, Francisco; Martínez-Sellés, Manuel; Sole-González, Eduard; Álvarez-García, Jesús; García-Pavia, Pablo; Varela-Roman, Alfonso; Sánchez, Pedro-Luis; Delgado, Juan-F; Noguera-Velasco, José-Antonio; Bayés-Genís, Antoni (Wiley, 2024-04)
    AIMS: There is a lack of specific studies assessing the impact of natriuretic peptide monitoring in the post-discharge management of patients with heart failure (HF) and preserved ejection fraction (HFpEF), throughout the ...
  • NT-proBNP to guide risk stratification after cardiac rehabilitation in patients with ST-segment elevation myocardial infarction 
    Pérez-Sole, Nerea; de-Dios, Elena; Gavara, José; Ríos-Navarro, César; Marcos-Garces, Víctor; Merenciano, Héctor; I; López-Bueno, Laura; Paya, Alfonso; de-la-Espriella, Rafael; Bayes-Genis, Antoni; Jiménez-Navarro, Manuel; Marín, Francisco; Núñez, Julio; Sanchis, Juan; Bodi, Vicente (ELSEVIER, 2025-07)
    INTRODUCTION AND OBJECTIVES: The use of N-terminal pro-brain natriuretic peptide (NT-proBNP) after ST-segment elevation acute myocardial infarction (STEMI) is unclear. We evaluated its prognostic significance after post-STEMI ...
  • Vitamin D in the prevention of left ventricular remodelling after an acute myocardial infarction: a randomized clinical trial 
    Tunon, José; Rodríguez-López, Carlos; Balaguer, Jorge; Gómez-Talavera, Sandra; Rojas, Antonio; Salamanca, Jorge; López-García, Cecilia; Esteve-Pastor, María-Asunción; Laffond, Ana; Herrera, Cristian; Escudier-Villa, Juan-M; Orejas, Miguel; Tomas, Marta; López-Álvarez, María; Arcas-Tomeo, Mireia; Llanos-Jiménez, Lucía; González-Lorenzo, Óscar; Kallmeyer, Andrea; Ibáñez, Borja; González-Casaus, María-Luisa; Hernández, Gonzalo; Espadas, Cristina; Lorenzo, Óscar; Mahillo-Fernández, Ignacio; Egido, Jesús; Sánchez, Pedro-Luis; Marín, Francisco; Alfonso, Fernando (SPRINGERNATURE, 2026-04-06)
    No clinical trial has yet assessed the effect of vitamin D on patients experiencing ST-segment elevation myocardial infarction (STEMI). In this multicentre, randomised (2:1), double-blind, placebo-controlled trial, 93 ...